Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is 10% at NATURES SUNSHINE PRODUCTS INC (NATR). They have made 2 open-market trades across 1 company since 2024, most recently 2024-10-15.

CIK 0001615258

Get an email the next time Shanghai Fosun Pharmaceutical (Group) Co., Ltd. files.Follow for free

Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.

0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
CFRX	7,900,000	$1.8M
NATR	64,167	$822K
Total		$2.7M

Shares reported on the most recent Form 4, priced at the 2024-10-17 close.

Get an email the next time Shanghai Fosun Pharmaceutical (Group) Co., Ltd. files

Free account. One email when the next filing comes in.

Follow Shanghai Fosun Pharmaceutical (Group) Co., Ltd. for free

Sell Track Record

Filings2

Only 2 decision-sell filings — too few to score

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.